Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Oncotarget|September 15, 2017
Tumor reductive therapies and antitumor immunityHuiqin Guo, Kangla TsungHuman Vaccines & Immunotherapeutics|September 12, 2015
In situ vaccine, immunological memory and cancer cureKangla Tsung, Jeffrey A NortonSurgery|September 10, 2002
Production of interferon-gamma by tumor-sensitized T cells is essential for interleukin-12-induced complete tumor eradicationNatalie C Lee, Kangla Tsung, Jeffrey A NortonArchives of Otolaryngology--Head & Neck Surgery|July 23, 2003
Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H miceAditi H Mandpe, Kangla Tsung, Jeffrey A NortonAnnals of Surgical Oncology|December 24, 2005
Inhibition of host signal transducer and activator of transcription factor 6 results in cure with cyclophosphamide and interleukin 12 immunotherapyJeffrey A Norton, Michelle Li, Natalie C Lee, et al.The Journal of Surgical Research|January 21, 2004
Antitumor immunity induced by dendritic cell-based vaccination is dependent on interferon-gamma and interleukin-12Jade S Hiramoto, Kangla Tsung, Melanie Bedolli, et al.Cancer Research|September 5, 2002
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejectionKangla Tsung, James P Dolan, Ying L Tsung, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2015
IL-12 augments antitumor responses to cycled chemotherapyLingbing Zhang, Dongdong Feng, Yingbin Hu, et al.Cancer Research|August 17, 2002
The role of IFN-gamma in rejection of established tumors by IL-12 : source of production and targetJennifer Gillary Segal, Natalie C Lee, Ying L Tsung, et al.Pageof 13